![Gregory Conn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gregory Conn
Chief Tech/Sci/R&D Officer at
PDS BIOTECHNOLOGY CORPORATION
Net worth: 108 882 $ as of 29/06/2026
Profile
Gregory L.
Conn is the founder of PDS Operating Corp.
Dr. Conn is Chief Scientific Officer at PDS Biotechnology Corp.
since 2005.
Dr. Conn was Director of the Process Development Department at Covance Biotechnology Services, Inc. from 1998 to 2000.
Dr. Conn completed graduate and doctorate degrees at Albert Einstein College of Medicine, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/01/2026 | 123,589 ( 0.22% ) | 108 882 $ | 29/06/2026 |
Gregory Conn active positions
| Companies | Position | Start |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Chief Tech/Sci/R&D Officer | 31/12/2004 |
Former positions of Gregory Conn
| Companies | Position | End |
|---|---|---|
Covance Biotechnology Services, Inc.
 Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 31/12/1999 |
PDS Operating Corp.
 PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease | Founder | - |
Training of Gregory Conn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
PDS Operating Corp.
PDS Operating Corp. Pharmaceuticals: MajorHealth Technology Develops novel cancer immunotherapies and vaccines for infectious disease | Health Technology |
Covance Biotechnology Services, Inc.
Covance Biotechnology Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
- Stock Market
- Insiders
- Gregory Conn
